NRX Pharmaceuticals (NRXP) Stock Price, Quote, News & History | Benzinga

NRX Pharmaceuticals Inc (NRXP) Stock Price, Quote, News & History

NRXPNASDAQ

Trade with Public

Trade with Public

$3.55

-0.07-1.93%

At close: Aug 27, 5:00 PM EST

$3.54

-0.0793-2.19%

Pre-Market: 4:02 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$3.55

Volume / Avg.

2.94K / 1.15M

Day Range

- - -

52 Wk Range

1.62 - 5.06

Market Cap

$153.30M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

20.89%

Days to Cover

5.78

Recent NRX Pharmaceuticals Inc News

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100M stock offering. XOS, Wellchange, and J-Star are top gainers while Jianzhi, NRx, and Volato are top losers.

Avi Kapoor

NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why

NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise capital for growth and operations.

Tanya Rawat

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, with a loss of 11 cents per share. FDA clearance received for clinical trial.

Avi Kapoor

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.

Vandana Singh

Partner Content

NRx Builds Momentum From FDA Progress To Strategic Expansion

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-19.77M

Investing Cash Flow (TTM)

-3.71M

Financing Cash Flow (TTM)

47.26M

Free Cash Flow (TTM)

-20.67M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

23.78M

Analyst Trends and Forecast

6

Mar

4

Apr

1

May

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$127.39M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

31.49

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-14.45%

Earnings Yield % (FWD)

-41.93%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.00

Company Debt

Total Debt

$412.00K

LT Debt

-

LT Debt Issuance (TTM)

$237.00K

LT Debt Repayment (TTM)

-$204.00K

Total Cash

$26.69M

Debt to Equity

-

Issuance of Debt (TTM)

$33.00K

Repayment of Debt (TTM)

-$204.00K

Key Statistics

Open

-

Close

$3.55

Volume / Avg.

2.94K / 1.15M

Day Range

- - -

52 Wk Range

1.62 - 5.06

Market Cap

$153.30M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

20.89%

Days to Cover

5.78

About

Sector

Health Care

Industry

Pharmaceuticals

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NRX Pharmaceuticals (NRXP) stock?

A

You can purchase shares of NRX Pharmaceuticals (NASDAQ:NRXP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NRX Pharmaceuticals (NRXP) competitors?

A

Other companies in NRX Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for NRX Pharmaceuticals (NRXP) stock?

A

NRX Pharmaceuticals has a consensus price target of $29.43.

Q

What is the current price for NRX Pharmaceuticals (NRXP)?

A

The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $3.5407 last updated August 31, 2026 at 2:23 AM EDT.

Q

Does NRX Pharmaceuticals (NRXP) pay a dividend?

A

There are no upcoming dividends for NRX Pharmaceuticals.

Q

When is NRX Pharmaceuticals (NASDAQ:NRXP) reporting earnings?

A

NRX Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is NRX Pharmaceuticals (NRXP) going to split?

A

There is no upcoming split for NRX Pharmaceuticals.

Q

What sector and industry does NRX Pharmaceuticals (NRXP) operate in?

A

NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.